Combination of Maca Colors
Combining maca colors has been documented in the literature, most extensively as a formulation known as Maca-GO. The research suggests that this proprietary combination of black, yellow, purple, and red maca supports:
-
Hormone health
-
Bone health
-
Adrenal health
-
Cardiometabolic health
-
Menopausal symptoms
Another combination of black, red, and yellow maca, known as MACAXS has been shown to impact testosterone levels in animals, though this is limited to one study.
Below is a compilation of the available literature (including animals and humans) for a combination of maca colors, with an overview and a summary of the findings provided.
January 2024
Concentrated Gelatinized Proprietary Phenotype Formulation of Lepidium peruvianum (maca) Positively Impacts Polycystic Ovarian Syndrome (PCOS), Premenstrual Syndrome (PMS), Dysmenorrhea, and Hormone Levels for Fertility Optimization: A Case Report
Human study, N=1, premenopausal women
In press: DOI: 10.29011/2577-2236.100177
Summary of Findings:
Taking a Concentrated Gelatinized Proprietary Phenotype Formulation of maca, known as MacaHarmony, the following results were achieved within 3 months:
1. Normalization of menstrual frequency (28-32 days)
2. Resolution of ovulation pain and cramping
3. Improved ovulation as evidenced by increased cervical mucus and libido
4. Decreased/resolved PMS duration and intensity of symptoms
5. Decreased menstrual blood flow and improved quality of menstrual blood (bright red vs. brown)
6. Decreased menstrual cramping (intensity, duration, and location)
Additionally, a comparative analysis of biomarkers revealed:
Hormone balancing as evidenced by a reduction of LH, normalization of LH/FSH ratio, and a reduction in E2 to optimal levels for fertility.
October 2023
Improvements in Premenstrual Syndrome, Primary Dysmenorrhea, and Menorrhagia with Natural Therapies: A Case Report
Human study, N=1, premenopausal woman
In Press: DOI: 10.29011/2577-2201.100207
Summary of Results:
Case report using a proprietary formulation of Lepidium peruvianum (MacaHarmony), 500 mg twice daily
Resolution of multiple PMS symptoms, including:
Balanced moods
Improved satiety
Reduced cystic acne
Regulated bowel movements
Resolution of menstrual pain and cramping (dysmenorrhea)
Lighter menstrual cycles
October 2023
An Integrative Approach for Improving and Managing Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD): A Case Report
Human study, N=1, premenopausal woman
In Press: DOI: https://doi.org/10.29011/2577-2201.100211
Summary of Findings
Case report using a proprietary formulation of Lepidium peruvianum (MacaHarmony), 500 mg twice daily. Bio-identical progesterone and magnesium supplementation was also used
Results
Resolution of premenstrual headaches in three months
Decreased menstrual cramping and reduced blood flow in three months
Resolution of intense psychiatric symptoms associated with a diagnosis of PMDD in three months
Normalization of LH levels was achieved in four months
December 2021
Nutritional management of surgically induced menopause: A case report
Human study, N=1, postmenopausal woman
PMID: 34253105
Summary of Findings
Case report, surgically-induced menopause, 1,000 mg twice daily of a combination product known as Maca-GO
Resolution of hot flashes and anxiety in 2 months
Improved mood and sleep
April 2016
Feeding hydroalcoholic extract powder of Lepidium meyenii (maca) increases serum testosterone concentration and enhances steroidogenic ability of Leydig cells in male rats
Animal study, male rats
PMID: 26174043
Summary of Findings:
A hydroalcoholic extract of a combination of maca colors (red, black, and yellow), known as MACAXS, was fed to male rats for 6 weeks.
The combination maca extract resulted in an increase in serum testosterone concentration.
December 2006
Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (III) Clinical responses of early-postmenopausal women to Maca in double blind, randomized, Placebo-controlled, crossover configuration, outpatient study
Human study, N=34, early postmenopausal women, ages 49-58
PMID: 23675006
Summary of Findings:
Two trials were conducted using a combination product known as Maca-GO, 1000 mg twice daily
Trial 1: N=22
Significant decrease in BMI and LH levels (p<0.05)
Significant increase in E2 (P<0.05)
Significant reductions in T3, cortisol, ACTH (p<0.05)
Significant increase in serum iron and plasma calcium levels (p<0.05)
Significant decrease in menopausal symptoms (p<0.001)
Trial 2: N=12
Increase in forearm bone density in 4 months, whereas the placebo group had a reduction in bone density during the same time.
Maca group had increase in E2 and decrease in FSH.
December 2006
Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (II) Physiological and Symptomatic Responses of Early-Postmenopausal Women to Standardized doses of Maca in Double Blind, Randomized, Placebo-Controlled, Multi-Centre Clinical Study
Human study, N=168 early menopausal women, ages 49-58
PMID: 23675005
Summary of Findings:
Two trials were conducted using a combination product known as Maca-GO, 1000 mg twice daily
Trial 1: N=102
Significant increase in E2 (P<0.001)
Significant decrease in FSH (p<0.05)
Significant increase in HDL levels (p<0.05)
Significant decrease in menopausal symptoms in one month (p<0.001) of treatment and further reduction in the second months of treatments, followed by an increase of symptoms when returning to placebo (p<0.001)
Trial 2: N=66
Significant decrease in FSH and LH (p<0.05),
Significant increase in E2 (p<0.05)
Significant reduction in menopausal symptoms (p<0.001)
September 2006
Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (I) Biochemical and Pharmacodynamic Study on Maca using Clinical Laboratory Model on Ovariectomized Rats
Animal study, ovariectomized rats
PMID: 23674989
Summary of Findings:
The study used a combination formulation known as Maca-GO with the aim of the study to determine toxicity of and to assess various effects of Maca-GO systemically.
The toxicity was > 15 g/kg of body weight in mice and > 5 g/kg body weight in rats, a dose much higher than would be administered in humans and would be classified as non-toxic.
In rats with functioning ovaries and after ovariectomy, a reduction in estradiol and progesterone levels were observed.
Maca-GO provided anti-depressant effects, improvements in cognitive function, reductions in cortisol, ACTH, total cholesterol, and triglycerides.
June 2006
Therapeutic Effects of Pre-Gelatinized Maca (Lepidium Peruvianum Chacon) used as a Non-Hormonal Alternative to HRT in Perimenopausal Women - Clinical Pilot Study
Human study, N=20 perimenopausal /menstruating women, ages 41-50
PMID: 23674976
Summary of Findings:
Women took 1000 mg twice daily of a combination product called Maca-GO for 2 months.
95% of women involved in the study had improvements in menopausal symptoms as assessed by Kupperman’s Menopausal Index
Significant reduction in menopausal symptoms: hot flashes, excessive sweating, interrupted sleep (all at p<0.01), nervousness, depression, heart palpitations (p<0.05)
Significant reduction in body weight, systolic and diastolic blood pressure (p<0.05)
Significant increase in HDL (p<0.01) and iron (p<0.05) levels
Significant increase in E2, FSH, and PG (p<0.01)
Significant reduction in ACTH (p<0.05)
February 2006
Short and long-term physiological responses of male and female rats to two dietary levels of pre-gelatinized maca (lepidium peruvianum chacon)
Animal study, male and female rats
PMID: 23674962
Summary of Findings:
A combination of maca colors known as Maca-GO was given to male and female rats in two different doses (0.75 g/kg (low dose) and 7.5 g/kg (high dose) body weight)
Significant reduction on body weight for male rats (p<0.001) at the high dose
Significant decrease in cortisol levels (p<0.001) with the low dose
Significant decrease in cortisol levels (p<0.01), triglycerides (p<0.05) with the high dose
Significant increase in estradiol levels (p<0.01) with the high dose.
Long term use (90 days) of the high dose of Maca-GO resulted in increased in blood glucose and progesterone levels.
June 2005
Use of gelatinized maca (lepidium peruvianum) in early postmenopausal women
Human study, N=20, early postmenopausal women, ages 45-62
PMID: 23674952
Summary of Findings:
A dose of 1000 mg twice daily of a combination product known as Maca-GO was taken for 2 or 8 months, with 1 month of a placebo.
At 2 and 8 months:
Significant decrease in FSH (P<0.05)
Significant increase in LH (P<0.05)
Significant reduction in menopausal symptoms in 2 and 8 months (p<0.05)
At month 8
Significant increase in E2 and PG (P<0.05)